Suppr超能文献

庆大霉素与阿米卡星——使用1000株临床分离株进行的体外比较

Gentamicin and amikacin---an in vitro comparison using 1000 clinical isolates.

作者信息

Forgan-Smith W R, McSweeney R J

出版信息

Aust N Z J Med. 1978 Aug;8(4):383-6. doi: 10.1111/j.1445-5994.1978.tb04906.x.

Abstract

The in vitro antimicrobial activities of gentamicin and amikacin against 1000 bacterial isolates from clinical material were compared. The minimum inhibitory concentrations were determined by an agar dilution technique. Both of these aminoglycoside antibiotics had a similar spectrum of activity, being highly active against most species of aerobic Gram negative bacilli. Gentamicin was more active than amikacin against most species of enterobacteria, Haemophilus influenzae and Staphylococcus aureus but amikacin was more active against a proportion of Klebsiella and Providencia isolates. For most isolates, the differences in activity between gentamicin and amikacin were small, however, amikacin achieves higher serum levels. Most resistant isolates in this survey did not influence patient mortality.

摘要

比较了庆大霉素和阿米卡星对1000株临床分离菌的体外抗菌活性。采用琼脂稀释法测定最低抑菌浓度。这两种氨基糖苷类抗生素具有相似的活性谱,对大多数需氧革兰氏阴性杆菌具有高度活性。庆大霉素对大多数肠杆菌科细菌、流感嗜血杆菌和金黄色葡萄球菌的活性比阿米卡星更强,但阿米卡星对部分克雷伯菌属和普罗威登斯菌属分离株的活性更强。对于大多数分离株,庆大霉素和阿米卡星之间的活性差异较小,然而,阿米卡星可达到更高的血清浓度。本次调查中大多数耐药分离株并未影响患者死亡率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验